Submitted by Anonymous (not verified) on 30 July 2024 - 13:31
Human medicines European public assessment report (EPAR): VidPrevtyn Beta, COVID-19 Vaccine (recombinant, adjuvanted), Date of authorisation: 10/11/2022, Revision: 4, Status: Withdrawn (authorisation)
Source: